Physician profile
Hasanian Jilaihawi
NPI 1699020859
$88,288.02
in general payments reported to CMS, 2019-2025
11 companies · $30K in 2025
The $30K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,563 · 2021: $7,280 · 2022: $2,371 · 2023: $8,437 · 2024: $21K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21K · Travel and Lodging: $16K · Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,731.03 |
| Travel and Lodging | $15,619.39 |
| Consulting Fee | $13,141.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $61,892.27 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $18,417.71 | 2019-2020 | |
| Medtronic, INC. | $2,780.19 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $1,635.37 | 2025 | |
| Heartflow, INC. | $1,135.07 | 2023-2025 | Ffrct |
| Boston Scientific Corporation | $876.16 | 2019-2025 | Watchman Flx, Sentinel, Avvigo Guidance System |
| Philips North America LLC | $703.37 | 2023 | |
| Abbott Laboratories | $471.78 | 2019-2023 | |
| Jenavalve Technology, INC. | $172.68 | 2024 | |
| Ge Healthcare | $146.05 | 2025 | |
| Pi-Cardia, INC. | $57.37 | 2025 | Shortcut |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasanian Jilaihawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.